BioLight Life Sciences
Manufacturing · Israel · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Kiryat Atidim Bldg 3 Fl 5, Tel Aviv, Tel...Website
www.bio-light.co.ilRevenue
<$5 MillionIndustry
About BioLight Life Sciences
BioLight Life Sciences Org Chart
Is BioLight Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at BioLight Life Sciences
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BioLight Life Sciences had a recent Job posting/layoffs
Product Launch: Get notified when BioLight Life Sciences launches new products
BioLight Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once BioLight Life Sciences has new funding data
Website visits: Recent activity has been detected on your website
Check out if BioLight Life Sciences is spiking on competitors!
Check if BioLight Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BioLight Life Sciences recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
BioLight Life Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioLight Life Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioLight Life Sciences.
BioLight Life Sciences Tech Stack
A closer look at the technologies used by BioLight Life Sciences
BioLight Life Sciences News & Media
Peripherex Receives FDA Registration for Eye Monitoring Software Providing a Seamless Homecare Glaucoma Solution
SAN FRANCISCO, CA, USA, October 31, 2023 /EINPresswire.com/ -- Peripherex, a pioneer in eye-care software diagnostics, proudly announces its first FDA registration, releasing the commercial product for its online-accessible visual field test, a …Lexitas Pharma Services, Inc. Partners With DiagnosTear Ltd. For The Use Of TeaRx™ In Ophthalmic Clinical Trials
TeaRx™ technology will be available to any of Lexitas’ clients conducting ophthalmic trials around the globe DURHAM, NC, UNITED STATES, September 13, 2023 /EINPresswire.com/ -- Lexitas Pharma Services, Inc. (“Lexitas”), an ophthalmic-focused product …Diagnostear, a subsidiary of BioLight Life Sciences Ltd, signed a binding Letter of Intent for merger, capital raise and listing on the Canadian Securities Exchange
TEL AVIV, Israel , June 12, 2023 /PRNewswire/ -- BioLight a publicly traded company on the Tel Aviv Stock Exchange (TASE: BOLT), specializing in investments in biomed companies focusing on eye diseases, announced that its subsidiary, Diagnostear has entered into a binding LOI for a merger...BioLight announces a joint cooperation agreement with Alexion (AstraZeneca Rare Disease) to explore an innovative technology based on natural tears for the diagnosis of retinal diseases
TEL AVIV, Israel, May 30, 2023 /PRNewswire/ -- BioLight (TASE: BOLT) is proud to report it has signed a research collaboration agreement with Alexion (AstraZeneca Rare Disease), focusing on exploring a groundbreaking technology that utilizes natural tears for the potential diagnosis of...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioLight Life Sciences
BioLight Life Sciences Ltd. specializes in ophthalmology, focusing on innovative solutions for eye health through a diverse portfolio of medical devices, diagnostics, and drug delivery technologies. The company aims to address global needs for effective eye care treatments and improve patient outcomes with products like DiagnosTears TeaRx for dry e... Read More
